# Events

Minus

<< Return to Main Menu
Add your World TB Day Event to this timeline![PDF - 189 KB]

            - Timelineicon January 24
January 24, 2022 – Call for the U.S. CDC TB Elimination Champions opens. Learn how to nominate a 2022 U.S. TB Elimination Champion!

            - Timelineicon February 18
February 18, 2022 – Deadline to submit 2022 U.S. TB Elimination Champions [DOC – 48 KB]

            - Timelineicon March 15 – 12:00 PM to 4:00 PM EST
Breathe Pennsylvania 2022 Tuberculosis Conference

            - Timelineicon Tuesdays, March 15 - April 26
Wisconsin Virtual TB Summit

            - Timelineicon March 18 – 12 PM to 4 PM (EST)
NYC World TB Day Conference

            - Timelineicon March 24
CDC, alongside partners and colleagues around the world, recognize World TB Day.

            - Timelineicon March 24 - 8 AM - 10 AM (EST)
Introduction to Emory TB Center and TRAC, Bite-Size TB Updates and Research Talks

            - Timelineicon March 24 - 8 AM to 12 PM (PST)
World TB Day Symposium

            - Timelineicon March 24 - 10 - 11:30 AM (EST)
Turning the Tide: Tech, Tools and TB (event link not available)

            - Timelineicon March 24 - 9 AM - 1 PM (CDT)
World TB Day From the Heartland News Desk Webcast (constantcontact.com)

            - Timelineicon March 24 - 12 - 1 PM (EST)
SNTC Presents: World TB Day with Thomas Goetz, MPH, author of “The Remedy (Robert Koch, Arthur Conan Doyle, and the Quest to Cure Tuberculosis)

            - Timelineicon March 24 - 4 PM - 5 PM (EST)
Global Synergies between Tuberculosis and Diabetes Mellitus: Disease Interdependence Across the Lifespan

            - Timelineicon March 28 - 12:30 - 1:30 PM (PST)
World TB Day at TB ECHO

            - Timelineicon March 30 - 9 AM – 4 PM (EST)
Indiana World TB Day Conference

            - Timelineicon April 14 - 2 - 3 PM (PST)
Latent TB Infection (LTBI) Webinar (event link not available)

            -      					Page last reviewed:  March 29, 2022Content source: 	Division of Tuberculosis Elimination     homeTuberculosis- Basic TB Facts plus icon   - How TB Spreads
  - Latent TB Infection and TB Disease
  - Signs & Symptoms
  - TB Risk Factors
  - Exposure to TB
  - TB Prevention
  - Vaccines
  - TB & HIV Coinfection
  - TB and Diabetes
  - TB Terms
- Personal Stories
- Testing & Diagnosis plus icon   - Who Should be Tested
  - Testing for TB Infection
  - Testing in BCG-Vaccinated Persons
  - TB Screening and Testing of Health Care Personnel
  - Testing During Pregnancy
  - Diagnosing latent TB infection and TB disease
- Treatment plus icon   - Deciding When to Treat Latent TB Infection
  - Treatment Regimens for Latent TB Infection (LTBI)
  - Treatment for TB Disease
  - Adverse Events
  - TB Treatment of Persons Living with HIV
  - TB Treatment and Pregnancy
  - TB Treatment for Children
  - Frequently Asked Questions
- Drug-Resistant TB
- Research plus icon   - TB Epidemiologic Studies Consortium plus icon     - Research Projects
    - Publications
  - TB Trials Consortium plus icon     - Study Descriptions
    - Background
  - Behavioral & Social Science Research
- Health Care Settings plus icon   - TB Infection Control in Health Care Settings
  - Resources for TB Screening and Testing of Health Care Personnel plus icon     - Frequently Asked Questions
- TB in Specific Populations plus icon   - Health Disparities
  - Asian Persons
  - Black or African American Persons
  - Hispanic or Latino Persons
  - Children
  - Pregnancy
  - Correctional Facilities
  - People Experiencing Homelessness
  - International Travelers
- Laboratory Information plus icon   - Drug Susceptibility Testing
  - False-Positive Investigation Toolkit
  - Interim Laboratory Biosafety Guidance for XDR  tuberculosis strains
  - Model Performance Evaluation Program (MPEP)
  - Rapid Molecular Testing to Detect Drug-Resistant TB in the US plus icon     - Executive Summary
    - Introduction
    - Background on Tests for Molecular Detection of DR
    - General Considerations and Principles for a Molecular DR Testing Service
    - Possible Scenarios and Scope of Testing for a Molecular DR Testing Service
    - Research Needs
    - General Recommendations of the Expert Panel
    - Communication Plan for the Report
    - Recommendations
    - References
    - Panel Members and CDC Participants
    - Appendix 1
    - Appendix 2
    - Appendix 3
  - The Uses of Nucleic Acid Amplification Tests for the Diagnosis of TB plus icon     - General Considerations
    - General Recommendations of the Expert Panel
    - Recommendations to ACET, CDC, DTBE
- Data & Statistics plus icon   - TB Incidence in the United States
  - Reported TB in the US, 2022 Surveillance Report plus icon     - National Data
    - Reporting Area Data
    - Risk Factors
    - Demographics
    - TB Treatment and Case Outcomes
    - Drug-Resistant TB
    - Molecular Surveillance
  - Tuberculosis in the United States, 2022 (Slide Set)
  - Archived Surveillance Reports and Slide Sets
  - 2021 State and City Report
  - Archived State and City Reports
- Professional Resources & Tools plus icon   - Tools for Healthcare Providers
  - Resources for TB Programs plus icon     - Strengthening Civil Surgeons’ Capacity to Improve LTBI Surveillance and Outcomes Among Status Adjusters
    - Notice of Funding Opportunity (NOFO)
    - Program Evaluation
  - TB Centers of Excellence
  - TB Elimination Alliance
  - TB Genotyping plus icon     - Conventional TB Genotyping
    - Whole Genome Sequencing
    - TB GIMS
    - Analytic Tools
  - Latent Tuberculosis Infection Resources
- Publications & Products plus icon   - Patient and Public Materials
  - Fact Sheets
  - Guidelines plus icon     - Control & Elimination
    - Drug-Resistant TB
    - Infection Control & Prevention
    - Laboratory & Genotyping
    - TB & HIV
    - TB in Specific Populations
    - Testing & Diagnosis
    - Treatment
    - Vaccines & Immunizations
    - Archived TB Guidelines
  - Guides & Toolkits plus icon     - Aggregate Reports
    - CDC TB Surveillance Training
    - Core Curriculum
    - Effective TB Interviewing for Contact Investigation
    - Ethnographic Guides
    - False-Positive Investigation Toolkit
    - Forging Partnerships to Eliminate Tuberculosis
    - Guide to Application of Genotyping
    - LTBI: A Guide for Primary Health Care Providers
    - Mantoux Tuberculin Skin Testing Products
    - Report of Verified Case of Tuberculosis (RVCT)
    - Self-Study Modules
    - TB Contact Investigation Interviewing Skills Course
    - TB eDOT Toolkit
    - Understanding the TB Cohort Review Process
  - Newsletters plus icon     - TB Notes, No. 4, 2023
    - TB Notes, No. 3, 2023
    - TB Notes. No. 2, 2023
    - TB Notes. No. 1, 2023
    - TB Notes, No. 4, 2022
    - TB Notes, No. 3, 2022
    - TB Notes, No. 2, 2022
    - TB Notes, No. 1, 2022
    - TB Notes, No. 4, 2021
    - TB Notes, No. 3, 2021
    - TB Notes, No. 2, 2021
    - TB Notes, No. 1, 2021
  - Pamphlets, Brochures, Booklets plus icon     - Questions and Answers
    - Patient Education Series
    - Tuberculosis - Get the Facts
    - Tuberculosis - The Connection between TB and HIV
    - 12-Dose Regimen for Latent TB Infection-Patient Education Brochure
  - Posters plus icon     - Mantoux Tuberculin Skin Test Wall Chart
    - World TB Day
    - Think TB
    - Stop TB
    - Take on TB
  - Reports & Articles plus icon     - DTBE Authored Journal Articles
    - Tuberculosis Laboratory Aggregate Reports
  - Slide Sets plus icon     - Introduction to Tuberculosis
    - Epidemiology of Tuberculosis Among Non-U.S.​–Born Persons in the United States, 1993–2016
    - Self-Study Modules on Tuberculosis, 1-5 Slide Sets
    - The Tuberculosis (TB) in Correctional Settings plus icon       - Facilitator Guide
    - Introduction to TB Genotyping
    - Epidemiology of Tuberculosis in Correctional Facilities, United States, 1993-2017
    - Prevention and Control of Tuberculosis in Correctional and Detention Facilities
    - Guidelines for Preventing the Transmission of M. TB in Health care Settings
    - Investigation of Contacts of Persons with Infectious TB
    - Epidemiology of Pediatric Tuberculosis in the United States
    - Targeted Tuberculosis Testing and Treatment of Latent Tuberculosis Infection
  - Electronic Tools & Resources
  - Web-Based Courses & Webinars plus icon     - TB 101 for Health Care Workers
  - Content Syndication
  - Infographics plus icon     - Social Media Graphics
    - Customizable Take on TB Infographic with Instructions
- Events
- World TB Day plus icon   - U.S. TB Champions
  - History
- Features plus icon   - TB Risk Factors
  - Treating Latent TB Infection with Short-Course Regimens
  - World Tuberculosis (TB) Day 2021
  - World Tuberculosis (TB) Day 2020
- Links plus icon   - State TB Control Offices
- About Us plus icon   - Mission Statement and Activities plus icon     - DTBE Strategic Plan
    - National TB Program Objectives
  - Organization Chart
  - Advisory Groups plus icon     - Federal TB Task Force
email_03Subscribe to get TB updates
To receive email updates about this page, enter your email address:
Email AddressWhat's this?Submit       - About CDC
- Contact Us
- 800-232-4636
FacebookTwitterInstagramLinkedInYoutubePinterestSnapchat-  CONTACT CDC  Contact UsCall 800-232-4636Email Us 
-  ABOUT CDC  - About CDC
- Jobs
- Funding
 
-  POLICIES  - Accessibility
- External Links
- Privacy
- Policies
- No Fear Act
- FOIA
- OIG
- Nondiscrimination
- Vulnerability Disclosure Policy
 
-  CONNECT WITH US  Facebook
Twitter
Instagram
LinkedIn

Youtube
Pinterest
Snapchat
Email

 
-  LANGUAGES  - Español
- 繁體中文
- Tiếng Việt
- 한국어
- Tagalog
- Русский
- العربية
- Kreyòl Ayisyen
- Français
- Polski
- Português
- Italiano
- Deutsch
- 日本語
- فارسی
- English
 
- U.S. Department of Health & Human Services
- Accessibility
- External Links
- Privacy
- Policies
- No Fear Act
- FOIA
- Nondiscrimination
- OIG
- Vulnerability Disclosure Policy
- USA.gov
                  SASstats        Exit Notification / Disclaimer PolicyClose**Links with this icon  indicate that you are leaving the CDC website.**- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
			For more information on CDC's web notification policies, see Website Disclaimers.		CancelContinue